Comprehensive Notes on Purine and Pyrimidine Metabolism

Definition: Nucleotides serve as the fundamental building blocks for the synthesis of nucleic acids, specifically $DNA$ (Deoxyribonucleic acid) and $RNA$ (Ribonucleic acid).
Categories of Nucleotides: * Purines: This category includes the nitrogenous bases Adenine and Guanine. * Pyrimidines: This category includes Cytosine, Thymine, and Uracil.
Biological Functions: * Storage and transmission of genetic information ( $DNA$ and $RNA$ ). * Serving as energy carriers, most notably $ATP$ (Adenosine Triphosphate) and $GTP$ (Guanosine Triphosphate). * Acting as essential components of coenzymes, such as $NAD^+$ (Nicotinamide Adenine Dinucleotide) and $FAD$ (Flavin Adenine Dinucleotide). * Functioning as signaling molecules within cellular pathways.

Origin: The synthesis process commences with Ribose-5-Phosphate, which is an intermediate derived from the Pentose Phosphate Pathway ( $PPP$ ).
Key Enzymatic Steps: 1. PRPP Synthesis: The formation of Phosphoribosyl Pyrophosphate ( $PRPP$ ) is catalyzed by the enzyme $PRPP$ synthetase. 2. IMP Formation: Through multiple enzymatic stages, Inosine Monophosphate ( $IMP$ ) is synthesized. $IMP$ serves as the parent purine nucleotide. 3. Conversion to Final Bases: $IMP$ is subsequently converted into Adenosine Monophosphate ( $AMP$ ) and Guanosine Monophosphate ( $GMP$ ).
Regulation of Pathway: The pathway is regulated through feedback inhibition. Elevated levels of $AMP$ , $GMP$ , and $IMP$ act to inhibit the synthesis process to prevent overproduction.

Purpose: This pathway allows the cell to recycle free purine bases, thereby significantly reducing the energy consumption required for total synthesis from scratch (De Novo).
Key Enzymes and Reactions: * HGPRT (Hypoxanthine-Guanine Phosphoribosyltransferase): This enzyme is responsible for converting Hypoxanthine and Guanine into $IMP$ and $GMP$ , respectively. * APRT (Adenine Phosphoribosyltransferase): This enzyme facilitates the conversion of Adenine into $AMP$ .
Clinical Significance: A deficiency in the $HGPRT$ enzyme leads to Lesch-Nyhan Syndrome. This condition is characterized by an excess of uric acid, which results in gout and significant neurological defects.

Degradative Pathways: 1. $AMP \rightarrow \text{Inosine} \rightarrow \text{Hypoxanthine} \rightarrow \text{Xanthine} \rightarrow \text{Uric Acid}$ . 2. $GMP \rightarrow \text{Guanosine} \rightarrow \text{Xanthine} \rightarrow \text{Uric Acid}$ .
Key Enzyme: Xanthine Oxidase is the critical enzyme that catalyzes the final steps of this process, converting hypoxanthine to xanthine and xanthine into uric acid.
Clinical Significance: Hyperuricemia, the accumulation of excessive uric acid in the blood, leads to Gout.

Mechanism: Unlike purines, pyrimidines are synthesized as a complete ring structure before being attached to the $PRPP$ sugar moiety.
Key Enzymatic Steps: 1. Carbamoyl Phosphate Synthesis: Catalyzed by $CPS-II$ (Carbamoyl Phosphate Synthetase II), this is recognized as the rate-limiting step of the pathway. 2. Orotic Acid and UMP Formation: The process involves the formation of Orotic Acid, followed by the synthesis of Uridine Monophosphate ( $UMP$ ). 3. Conversion: $UMP$ is later converted into Cytidine Monophosphate ( $CMP$ ), Thymidine Monophosphate ( $TMP$ ), and Uridine Triphosphate ( $UTP$ ).
Regulation: The pathway is controlled by feedback inhibition, primarily mediated by $UTP$ .

Salvage Pathway: Free pyrimidine bases such as Uracil, Thymine, and Cytosine can be recycled into the nucleotide pool via the enzyme pyrimidine phosphoribosyltransferase.
Degradation Pathway: Pyrimidines are broken down into highly soluble metabolic products, specifically $\beta-alanine$ and $\beta-aminoisobutyrate$ , which are subsequently excreted via urine.
Clinical Significance: A deficiency in the enzyme $UMP$ Synthase leads to Orotic Aciduria, a condition marked by the buildup of orotic acid.

Lesch-Nyhan Syndrome: Caused by a deficiency in $HGPRT$ . Clinical manifestations include gout, mental retardation, and characteristic self-mutilation behaviors.
Gout: Resultant from high levels of uric acid ( $\text{Hyperuricemia}$ ), leading to the deposition of crystals in joints and subsequent joint inflammation.
SCID (Severe Combined Immunodeficiency): Caused by a deficiency in the enzyme Adenosine Deaminase. This leads to profound dysfunction in both T and B lymphocytes.
Orotic Aciduria: Resultant from a defect in the enzyme $UMP$ synthase, which clinically manifests as Megaloblastic anemia.

Gout Treatments: * Allopurinol: Functions as a Xanthine Oxidase Inhibitor to lower the production of uric acid. * Febuxostat: Serves as an alternative Xanthine Oxidase Inhibitor for those who cannot use allopurinol.
Cancer Treatments: * 5-Fluorouracil (5-FU): This drug inhibits the enzyme thymidylate synthase, thereby decreasing $DNA$ synthesis in rapidly dividing cancer cells. * Methotrexate: This agent inhibits dihydrofolate reductase, which reduces the availability of precursors for purine synthesis.

Purine and pyrimidine metabolism is vital for nucleic acid synthesis, efficient energy metabolism, and overall cellular function.
The balance between De Novo pathways and salvage pathways ensures a steady supply of nucleotides while managing the cell's energy budget.
Dysregulation of these pathways results in severe metabolic diseases including Gout, $SCID$ , Lesch-Nyhan Syndrome, and Orotic Aciduria.
Modern therapeutic strategies target specific enzymes within these pathways to effectively manage and treat these metabolic disorders.

Which of the following is a purine?
- A) Cytosine
- B) Thymine
- C) Guanine
- D) Uracil
  Answer: C) Guanine
What is the primary role of ATP?
- A) Genetic information storage
- B) Energy carrier
- C) Signaling molecule
- D) Component of coenzymes
  Answer: B) Energy carrier
What enzyme is responsible for the conversion of Hypoxanthine to IMP in the purine salvage pathway?
- A) APRT
- B) HGPRT
- C) PRPP synthetase
- D) Xanthine oxidase
  Answer: B) HGPRT
Which condition is characterized by a deficiency of HGPRT?
- A) Orotic Aciduria
- B) SCID
- C) Gout
- D) Lesch-Nyhan Syndrome
  Answer: D) Lesch-Nyhan Syndrome
What is the function of Xanthine oxidase?
- A) Converts AMP to Inosine
- B) Converts Hypoxanthine to Xanthine
- C) Converts UMP to CMP
- D) Converts GMP to Guanosine
  Answer: B) Converts Hypoxanthine to Xanthine